(0.17%) 5 108.38 points
(0.27%) 38 342 points
(0.22%) 15 962 points
(-1.32%) $82.74
(6.34%) $2.05
(-0.08%) $2 345.30
(-0.25%) $27.47
(3.95%) $958.55
(-0.20%) $0.933
(-0.33%) $10.99
(-0.53%) $0.796
(1.66%) $93.40
-0.91% $ 115.24
Live Chart Being Loaded With Signals
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics...
Stats | |
---|---|
Dagens volum | 1.63M |
Gjennomsnittsvolum | 808 389 |
Markedsverdi | 14.46B |
EPS | $0 ( 2024-02-12 ) |
Neste inntjeningsdato | ( $0 ) 2024-05-09 |
Last Dividend | $0.0700 ( 2023-07-20 ) |
Next Dividend | $0 ( N/A ) |
P/E | 41.45 |
ATR14 | $3.13 (2.60%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-15 | Gonzales Anita | Buy | 248 | Common Stock |
2023-12-15 | Gonzales Anita | Buy | 706 | NQ Stock Option (right to buy) |
2023-11-27 | Michas Alexis P | Sell | 250 | Common Stock |
2023-11-28 | Michas Alexis P | Sell | 230 | Common Stock |
2023-06-15 | Gonzales Anita | Buy | 329 | Common Stock |
INSIDER POWER |
---|
28.89 |
Last 100 transactions |
Buy: 270 652 | Sell: 165 378 |
Volum Korrelasjon
PerkinElmer Inc Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
PerkinElmer Inc Korrelasjon - Valuta/Råvare
PerkinElmer Inc Økonomi
Annual | 2022 |
Omsetning: | $3.31B |
Bruttogevinst: | $1.99B (60.08 %) |
EPS: | $4.59 |
FY | 2022 |
Omsetning: | $3.31B |
Bruttogevinst: | $1.99B (60.08 %) |
EPS: | $4.59 |
FY | 2022 |
Omsetning: | $3.31B |
Bruttogevinst: | $1.99B (60.08 %) |
EPS: | $4.59 |
FY | 2021 |
Omsetning: | $5.07B |
Bruttogevinst: | $2.85B (56.27 %) |
EPS: | $7.39 |
Financial Reports:
No articles found.
PerkinElmer Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0225 | 1983-04-18 |
Last Dividend | $0.0700 | 2023-07-20 |
Next Dividend | $0 | N/A |
Payout Date | 2023-08-11 | |
Next Payout Date | N/A | |
# dividends | 164 | -- |
Total Paid Out | $10.25 | -- |
Avg. Dividend % Per Year | 0.11% | -- |
Score | 4.42 | -- |
Div. Sustainability Score | 9.50 | |
Div.Growth Potential Score | 2.99 | |
Div. Directional Score | 6.24 | -- |
Year | Amount | Yield |
---|---|---|
1983 | $0.0675 | 1.00% |
1984 | $0.100 | 1.24% |
1985 | $0.120 | 1.52% |
1986 | $0.130 | 1.36% |
1987 | $0.140 | 1.98% |
1988 | $0.150 | 1.78% |
1989 | $0.170 | 2.38% |
1990 | $0.190 | 2.20% |
1991 | $0.210 | 2.66% |
1992 | $0.245 | 2.03% |
1993 | $0.325 | 3.27% |
1994 | $0.280 | 3.15% |
1995 | $0.350 | 4.79% |
1996 | $0.280 | 2.35% |
1997 | $0.280 | 2.82% |
1998 | $0.280 | 2.68% |
1999 | $0.280 | 1.94% |
2000 | $0.280 | 1.35% |
2001 | $0.280 | 0.58% |
2002 | $0.280 | 0.80% |
2003 | $0.280 | 3.17% |
2004 | $0.280 | 1.60% |
2005 | $0.280 | 1.27% |
2006 | $0.280 | 1.17% |
2007 | $0.280 | 1.28% |
2008 | $0.280 | 1.10% |
2009 | $0.280 | 1.98% |
2010 | $0.280 | 1.36% |
2011 | $0.280 | 1.08% |
2012 | $0.280 | 1.36% |
2013 | $0.280 | 0.87% |
2014 | $0.280 | 0.68% |
2015 | $0.280 | 0.64% |
2016 | $0.280 | 0.53% |
2017 | $0.280 | 0.53% |
2018 | $0.280 | 0.38% |
2019 | $0.280 | 0.36% |
2020 | $0.280 | 0.28% |
2021 | $0.280 | 0.19% |
2022 | $0.280 | 0.15% |
2023 | $0.210 | 0.15% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0790 | 1.500 | 8.42 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0118 | 1.200 | 9.61 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0216 | 1.500 | -0.871 | -1.306 | [0.1 - 1] |
payoutRatioTTM | 0.0527 | -1.000 | 9.47 | -9.47 | [0 - 1] |
currentRatioTTM | 2.58 | 0.800 | 2.11 | 1.689 | [1 - 3] |
quickRatioTTM | 1.974 | 0.800 | 3.10 | 2.48 | [0.8 - 2.5] |
cashRatioTTM | 0.974 | 1.500 | 5.70 | 8.55 | [0.2 - 2] |
debtRatioTTM | 0.317 | -1.500 | 4.72 | -7.08 | [0 - 0.6] |
interestCoverageTTM | 5.12 | 1.000 | 9.21 | 9.21 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.616 | 2.00 | 9.46 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.240 | 2.00 | 9.38 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.573 | -1.500 | 7.71 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.589 | 1.000 | 3.51 | 3.51 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.125 | 1.000 | 9.51 | 9.51 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0450 | 1.000 | -0.861 | -0.861 | [0.2 - 2] |
assetTurnoverTTM | 0.149 | 0.800 | -2.34 | -1.870 | [0.5 - 2] |
Total Score | 9.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 86.07 | 1.000 | 1.407 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0216 | 2.50 | -0.560 | -1.306 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.240 | 2.00 | 9.59 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.0607 | 1.500 | 8.48 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.616 | 2.00 | 9.46 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0527 | 1.500 | 9.47 | -9.47 | [0 - 1] |
pegRatioTTM | -1.980 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0953 | 1.000 | -0.116 | 0 | [0.1 - 0.5] |
Total Score | 2.99 |
PerkinElmer Inc
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.